
Sign up to save your podcasts
Or


Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
By The Lancet Group5
11 ratings
Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

138 Listeners

135 Listeners

324 Listeners

498 Listeners

64 Listeners

102 Listeners

37 Listeners

6 Listeners

129 Listeners

112,502 Listeners

20 Listeners

1,145 Listeners

21 Listeners

0 Listeners

0 Listeners

2 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

59 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners